Literature DB >> 16632740

Dynamic CT Evaluation of Tumor Vascularity in Renal Cell Carcinoma.

Jin Hong Wang1, Peng Qiu Min, Pei Jun Wang, Wei Xia Cheng, Xiu Hui Zhang, Yu Wang, Xiao Hu Zhao, Xin Qing Mao.   

Abstract

OBJECTIVE: The purpose of our study was to evaluate the correlation between the enhancement parameters of dynamic CT; the carcinoma tissue microvessel density (MVD, a hotspot method to provide a histologic assessment of tumor vascularity); and tumor nuclear grade in renal cell carcinomas. SUBJECTS AND METHODS: Twenty-four patients with histologically diagnosed renal cell carcinoma underwent dynamic enhanced CT. Enhancement parameters, slope of the time-density curve, the density difference before and after tissue enhancement (deltaH), tissue blood ratio (TBR), and area under the time-density curve (AR), were calculated for all lesions. Pathology slides corresponding to the CT plane were stained using mouse antihuman CD34 monoclonal antibody and H and E. Fuhrman nuclear grade was used. Vascular hot spots of microvessels were recorded. Spearman's rank correlation was performed to determine the strength of the relationship between enhancement parameters, MVD determinations, and tumor nuclear grade.
RESULTS: MVD with CD34 staining revealed uneven distribution of positively stained vascular endothelial cells in renal cell carcinoma lesions. Heterogeneous distribution of contrast enhancement was seen among and within individual tumors. The tumors appeared as uneven patterns on time-density curves of renal cell carcinoma lesions. Enhancement parameters of H (median, 21.0 H; range, 2.2-105.8 H), TBR (median, 39%; range, 10.7-154.7%), AR (median, 1.58 H x sec; range, 0.23-3.67 H x sec), and slope (median, 2.76; range, 0.53-6.76) varied greatly. Renal cell carcinoma tissue MVD significantly correlated with all enhancement parameters of dynamic CT. The correlation coefficients (r) were 0.62, 0.54, 0.55, and 0.44, respectively, for delta H, slope, TBR, and AR (p < 0.0 5). All enhancement parameters did not significantly correlate with tumor nuclear grade. They were not predictive of nuclear grade.
CONCLUSION: Enhancement parameters of dynamic CT may be suited to evaluate tumor vascularity in vivo. Dynamic enhanced CT images may reflect the heterogeneity of tumor angiogenesis on the basis of the correlation between enhancement parameters and MVD of renal cell carcinoma.

Entities:  

Mesh:

Year:  2006        PMID: 16632740     DOI: 10.2214/AJR.04.1408

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  30 in total

Review 1.  Dynamic contrast-enhanced imaging techniques: CT and MRI.

Authors:  J P B O'Connor; P S Tofts; K A Miles; L M Parkes; G Thompson; A Jackson
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

2.  Pathological implications of areas of lower enhancement on contrast-enhanced computed tomography in renal-cell carcinoma: additional information for selecting candidates for surveillance protocols.

Authors:  Miguel Villalobos-Gollás; Bernardo Aguilar-Davidov; Carolina Culebro-García; Martha O Gómez-Alvarado; Priscila Rojas-Garcia; Raúl Ibarra-Fombona; Norma Uribe-Uribe; Guillermo Feria-Bernal; Ricardo Castillejos-Molina; Mariano Sotomayor; Fernando Gabilondo; Francisco Rodríguez-Covarrubias
Journal:  Int Urol Nephrol       Date:  2012-05-22       Impact factor: 2.370

3.  The essence of the Japan Radiological Society/Japanese College of Radiology Imaging Guideline.

Authors:  Yasuyuki Yamashita; Sadayuki Murayama; Masahiro Okada; Yoshiyuki Watanabe; Masako Kataoka; Yasushi Kaji; Keiko Imamura; Yasuo Takehara; Hiromitsu Hayashi; Kazuko Ohno; Kazuo Awai; Toshinori Hirai; Kazuyuki Kojima; Shuji Sakai; Naofumi Matsunaga; Takamichi Murakami; Kengo Yoshimitsu; Toshifumi Gabata; Kenji Matsuzaki; Eriko Tohno; Yasuhiro Kawahara; Takeo Nakayama; Shuichi Monzawa; Satoru Takahashi
Journal:  Jpn J Radiol       Date:  2016-01       Impact factor: 2.374

Review 4.  Contemporary imaging modalities for the surveillance of patients with renal cell carcinoma.

Authors:  Matthew K Tollefson; Naoki Takahashi; Bradley C Leibovich
Journal:  Curr Urol Rep       Date:  2007-01       Impact factor: 3.092

Review 5.  Targeted therapies in renal cell cancer: recent developments in imaging.

Authors:  Astrid A M van der Veldt; Martijn R Meijerink; Alfons J M van den Eertwegh; Epie Boven
Journal:  Target Oncol       Date:  2010-07-14       Impact factor: 4.493

6.  Advances of multidetector computed tomography in the characterization and staging of renal cell carcinoma.

Authors:  Athina C Tsili; Maria I Argyropoulou
Journal:  World J Radiol       Date:  2015-06-28

Review 7.  Hypoxia, angiogenesis, and metabolism in the hereditary kidney cancers.

Authors:  John C Chappell; Laura Beth Payne; W Kimryn Rathmell
Journal:  J Clin Invest       Date:  2019-01-07       Impact factor: 14.808

8.  Enhancement patterns of pancreatic adenocarcinoma on conventional dynamic multi-detector row CT: correlation with angiogenesis and fibrosis.

Authors:  Yuki Hattori; Toshifumi Gabata; Osamu Matsui; Kentaro Mochizuki; Hirohisa Kitagawa; Masato Kayahara; Tetsuo Ohta; Yasuni Nakanuma
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

9.  Can perfusion CT assessment of primary colorectal adenocarcinoma blood flow at staging predict for subsequent metastatic disease? A pilot study.

Authors:  Vicky Goh; Steve Halligan; David M Wellsted; Clive I Bartram
Journal:  Eur Radiol       Date:  2008-08-15       Impact factor: 5.315

10.  Dynamic evolutionary changes in blood flow measured by MDCT in a hepatic VX2 tumor implant over an extended 28-day growth period: time-density curve analysis.

Authors:  Hanping Wu; Agata A Exner; Hong Shi; Joshua Bear; John R Haaga
Journal:  Acad Radiol       Date:  2009-12       Impact factor: 3.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.